Delivery Order SPE2DB22D2007-SPE2DB26FH6SA
- Not listed
- The Defense Logistics Agency awarded a $1,092.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with a completion date of September 11, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $5,065.20 to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. This non-competitive, firm fixed-price delivery order was issued on October 30, 2025, with an ultimate completion date of October 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,989.35 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes valued at $6,552.00, with an ultimate completion date of October 30, 2025. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 22, 2025, for the supply of Copaxone 40 mg/ml syringes. This firm fixed price delivery order, valued at $2,163.92, represents a competitive award with no set-aside designation and is scheduled for completion by September 23, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/mL syringes under a firm fixed-price contract with a ceiling value of $1,128.54. This non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a direct delivery order fulfillment. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,580.20 to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, utilizes firm fixed price terms and was competitively awarded without set-aside provisions. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Copaxone 40 mg/mL syringes with a firm fixed price ceiling value of $2,645.73. This is a non-set-aside competitive award, reflecting AmerisourceBergen's qualification to compete openly for federal medical procurement needs. The delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Copaxone 40 mg/ml syringes valued at $1,712.99. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025, under a Firm Fixed Price contract type with no set-aside designation. This delivery order represents a competitive procurement action and falls under the company's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,522.65 to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/mL syringes. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025. This delivery order is a child contract issued under...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6SADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Copaxone 40 mg/ml syringes with a ceiling value of $3,864.84 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA and related agencies, consistently demonstrating capability to fulfill competitive procurement requirements across a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Copaxone, a multiple sclerosis treatment, represents a routine fulfillment under the company's established prime vendor agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 10/31/25 |